The use of prostaglandins in pharmacolo~ic doses to maintain Several markers of growth and biochemical development in the rat were studied after administration of prostacyclin (PG12) and 16, 16-dimethyl prostaglandin Ez (16, 16DM PGE2). Intermittent administration of PGIz for 3 days to 10-and 19-day-old animals, with subsequent sacrifice at 14 and 23 days, resulted in significant dose related decreases in growth at 23 days. Total sucrase and maltase (glucoamylase) activities were elevated compared to controls at 14 days. Total activities of these enzymes were decreased in postweaned 23-day-old animals, but specific activities per mg intestinal protein were not significantly different. 16, 16DM PGEz administered continuously between day 10-16 of life caused alterations in growth as well as increases in sucrase and maltase (glucoamvlase) activities. Exoeenouslv administered prostaglan- A paucity of data exists concerning the physiologic role of prostaglandins in the gastrointestinal tract of the developing fetus and neonate. Although these compounds elicit potent pharmacologic responses and are ubiquitous in the body, their therapeutic use causes some concern.
A paucity of data exists concerning the physiologic role of prostaglandins in the gastrointestinal tract of the developing fetus and neonate. Although these compounds elicit potent pharmacologic responses and are ubiquitous in the body, their therapeutic use causes some concern.
In adult animals prostaglandins may influence many aspects of gastrointestinal function including motility, secretion, mucosal blood flow, mucous production, and ulcer formation (1) . Both PGE and lesser amounts of PGF are present in the organs of the G I tract (2, 13) . PGIz is also found in the rat stomach (12) . It has gastric antisecretory and cytoprotective properties similar to those of PGEz (14) .
There is speculation that prostaglandins may protect the small intestinal mucosa from luminal insults by regulating mucous secretion. Robert (15) has shown that prostaglandins may have a "cvtoprotective" effect on the G I tract. Gastric and small intestinal ulcers' can be prevented, in a dose-dependent fashion, by oral and subcutaneous ~rostaalandin administration.
If the prostaglandFns play an important role in vascular homeostasis, then alterations in their synthesis or pool sizes might produce aberrations in blood flow and pathologic consequences. Indomethacin decreases the rate of formation and changes the composition of gastric mucus in the dog, making it more susceptible to damage by acid and peptic digestion (10). It is known that synthesis of the mesenteric vasodilators PGE, and PGIz are blocked by indomethacin (3). It is, therefore, of concern that the use of prostaglandin inhibitors such as indomethacin might lead to an increase in the incidence of NEC by compromising mesenteric blood flow. ductal patency in neonates withAcyanotic congenital heart disease has been associated with side effects. Among these side effects are pyrexia, apnea, cutaneous flushing, hypotension, and long bone periosteal proliferation. The long term effects of exogenous administration of the prostaglandins on the development of the rapidly growing mammal is poorly understood.
The purpose of this investigation was to: ( 1 ) use an animal model to study the effects of certain prostaglandins on growth and (2) to investigate the alterations caused by prostaglandins in small intestinal disaccharidase content.
The data suggest alterations in somatic growth and intestinal biochemical development brought about by exogenously administered prostaglandins.
MATERIALS AND METHODS

Prostaglandins.
Representatives from two classes of prostaglandins used in this study were PG12 and 16, 16DM PGE,, generously made available by Dr. Mary Ruwart from Upjohn, Kalamazoo, Michigan. The methyl analogue of PGE was chosen for this study because it can be mixed with triacetin and infused continuously using osmotic minipumps.
Preliminary studies (16) have demonstated the stability of 16, 16DM PGE2 in triacetin. Less than 10% degradation of the 16, 16DM PGE2 triacetin solution in minipumps is seen over a 2-wk period. Both PGIz and 16, 16DM PGEz were chosen because of their previously described effects on the intestine (14, 15) . Doses of the exogenously administered prostaglandins were chosen such that they would be in the range of the dose of PGEl administered to the human neonate for maintenance of ductal patency.
Morphologic parameters investigated were total body, liver, kidney, gut, and lung weights after intermittent PGIp and continuous 16, 16DM PGE2 administration to rat pups. Markers of biochemical intestinal development consisted of total small intestine protein, disaccharidase activities and aboral gradients of disaccharidase activity.
Experimental design. Prostacyclin was dissolved in a 0.2% glycine, 1.5% NaCl, 2.5% mannitol buffer (pH 10.5) and injected subcutaneously three times a day with 0.2 cc doses of 0.1. 0.2, or 0.3 mg/kg to groups of five experimental animals. Littermate control pups were injected with 0.2 ml of buffer alone. Experimental and control animals were sacrificed at 14 and 23 days of age after four days of treatment.
16, 16DM PGE2 was administered in triacetin as a vehicle using Alzet osmotic minipumps (Palo Alto, California) with a 200 pliter reservoir, model 2002. Minipumps were inserted subcutaneously (at 10 days of age) in the abdominal area as recommended by the manufacturer under Fluothane anesthesia after a 3-h fast. Experimental (10-day-old) animals were continuously infused with 16, 16DM PGE2 at a rate of 0.3 p. kg-'. min-', based upon the weight of the animal at 10 days. Control animals were similarly infused with triacetin alone using the osmotic minipumps. The experimental and control animals were sacrificed at 16 days of age.
Aboral gradients of small intestinal disaccharidase activity were examined in animals, which were administered PGI2 for 4 days and 16, 16DM PGE2 for 6 days. All animals were sacrificed at similar times of day.
Analyses. Gross morphologic measurements included total body, total small intestine, liver, lung, kidney, and brain weights. Gut lengths were measured from pylorus to the ileocecal junction. Entire small intestines were gently flushed with cold saline and homogenized 1:5 (small intestinal weight:volume of buffer) in 10 mM sodium phosphate buffer, pH 6.0, 0.002% Triton X-100 for biochemical analyses. The aboral gradient analyses were performed on nine equally sized segments of intestine from pylorus to the ileocecal junction after flush with cold saline and homogenization. Units of enzyme and protein mass were added together from the segments for determination of the entire small intestinal units of enzyme activity and specific activities. Fresh homogenate was precipitated in 0.4 N perchloric acid (1:3) for protein assay.
Disaccharidase activities were assayed at 37OC and 250 pliter reaction volume in 50 mM sodium phosphate buffer, pH 6.0, using 0.04 M sucrose (for sucrase activity), 0.0156 M maltose (glucoamylase activity), and 0.0156 M cellobiose (lactose activity). Cellobiose is used as a substrate to determine membrane bound lactase activity independent of intracellular acid beta-glactosidase activity (18) . Units of disaccharidase activity are pmole substrate hydrolyzed per min (total enzyme activity) per total small intestine or per segment in the aboral gradient studies. Specific activity was expressed as activity units per mg protein. Protein was determined by the method of Lowry, et al. (9) . Some small intestine was also examined by light microscopy on tissues fmed in 10% formalin, embedded in parafffin sectioned along their longitudinal axis and stained with hemotoxylin-eosin.
Animals and reagents. Infant Sprague-Dawley rats with their mothers were obtained from King Animal Labs (Madison, Wisconsin). Cellobiose (Calbiochem), sucrose (Mallinckrodt), and maltose (Sigma Chemical Company), and Statzyme Glucose (Worthington) were purchased from the indicated sources. Statistical analyses. Comparisons of the experimental and control littermates were made using the analysis of variance for a randomized block design (with litters as blocks) both of 16, 16DM PGE2 and PG12. A priori comparisons between treatment versus controls were made using Dunnetts' procedure; a priori tests for trend with dosage of PGIz were tested with Fisher's least significant difference procedure; a posteriori contrasts were tested with Scheffe's procedure.
RESULTS
The animals administered PGIz between 10-13 days demonstrated no differences in body, kidney, lung, liver or gut weights. No differences were seen in gut length or gut protein mass. But differences were seen in sucrase and maltase total activities and specific activities per mg protein per total small intestine ( Table   Table 1 Total intestinal lactase (U.E. = pmole/min/ total small intestine) Lactase (U.E./cm small intestine) Lactase specific activity (U.E./mg protein) Total intestinal maltase (U.E. = pole/min/ total small intestine) Maltase (U.E./cm small intestine) Maltase specific activity (U.E./mg protein) Total intestinal sucrase (U.E. = pmole/min/ total small intestine) Sucrase (U.E./cm small intestine) Sucrase specific activity (U.E./mg protein) ' NS, not significant. ). An increasing trend in the activity of lactase was also demonstrated in the animals administered PGIz. Of interest are the differences between the 23-day-old control and PGIz-administered animals in terms of body, kidney, gut weights and gut protein mass (Table 2 ). No differences in liver or lung weights or gut lengths were detected in the 23-day-old animals administered PG12. Biochemical differences in the animals administered PGI2 between 19-22 days consisted of significant decreases in total small intestinal activities of lactase, sucrase, and maltase; however, the specific activities of these enzymes per mg protein did not demonstrate differences ( Table 2 ).
The results of the studies of 16, 16DM PGEz-administered animals are seen in Table 3 . Administration of 16, 16DM PGEz by continuous minipump infusion significantly decreased change in total body and liver weights. Sucrase and maltase were increased in terms of total activity; however, sucrase and maltase specific activities per mg protein were not increased in the 16-day-old animals. Lactase activities were not significantly altered by the administration of 16, 16DM PGE2.
Consistently elevated trends in sucrase and maltase were seen across the entire aboral gradient in the animals administered PGIz with the greatest differences seen in the mid-small intestinal regions (Fig. 1) .
No differences in histology were seen between control and experimental animals by light microscopy. Mitotic activity was sparse in both control and experimental groups and no discernible differences were appreciated.
Whether the prostaglandins in this study cause a precocious increase in sucrase activity through direct action or through stimulation of glucocorticoid, thyroxine, a second messenger such as cyclic nucleotides, nutritional factors, or mesenteric vasodilators remains to be elucidated.
In summary, the prostaglandins are ubiquitous compounds in the body. When administered exogenously, they may alter growth and biochemical development in the rat. The precocious increase in disaccharidase activity represents a potentially beneficial effect, but the mechanisms of this increase are poorly understood and warrant further investigation.
